Training program to improve HIV prevention efforts in Georgia
Georgian Implementation Science Fogarty Training Program (GIFT)
This study is working to improve HIV prevention efforts in Georgia by training local teachers and students to better use data and strategies, so they can help more people at risk and tackle the stigma that makes it harder for them to get the help they need.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-11061071 on NIH RePORTER |
What this research studies
This research aims to enhance the implementation of evidence-based interventions for HIV prevention in Georgia, where new infections and mortality rates have significantly increased. The program will focus on training local faculty and students in biostatistics and implementation science to better analyze and apply data for effective HIV prevention strategies. By collaborating with Yale University, the initiative seeks to build local expertise and improve the coverage and effectiveness of existing HIV prevention tools among key at-risk populations. The training will also address issues of stigma and discrimination that hinder effective intervention.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals from key at-risk populations, such as men who have sex with men (MSM) and people who inject drugs (PWID), in Georgia.
Not a fit: Patients outside of Georgia or those not belonging to key at-risk populations may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to a significant reduction in HIV infections and related mortality in Georgia.
How similar studies have performed: Other research has shown success in similar training programs aimed at improving public health interventions, indicating a promising approach.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Altice, Frederick Lewis — Yale University
- Study coordinator: Altice, Frederick Lewis
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.